Eli Lilly Corp. buy BMO Capital Markets
Start price
01.05.24
/
50%
€726.70
Target price
01.05.25
€936.94
Performance (%)
-2.30%
End price
02.05.25
€710.00
Summary
This prediction ended on 02.05.25 with a price of €710.00. With a performance of -2.30%, the BUY prediction for Eli Lilly Corp. by BMO_Capital_Markets closed slightly in the red. BMO_Capital_Markets has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. Dividends of €5.04 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | 1.439% | 1.439% | 0.581% |
| iShares Core DAX® | 0.985% | 8.314% | 7.032% |
| iShares Nasdaq 100 | 2.067% | 16.765% | 35.952% |
| iShares Nikkei 225® | 2.270% | 15.605% | 46.568% |
| iShares S&P 500 | 1.043% | 11.077% | 26.456% |
Comments by BMO_Capital_Markets for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at BMO Capital Markets from $900.00 to $1,001.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€690.00
20.10.25
20.10.25
€797.57
20.10.26
20.10.26
15.42%
30.04.26
30.04.26
Stopped prediction by BMO_Capital_Markets for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€803.70
06.11.25
06.11.25
€955.79
06.11.26
06.11.26
-0.91%
30.04.26
30.04.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€842.00
03.07.24
03.07.24
€928.23
03.07.25
03.07.25
-21.39%
04.07.25
04.07.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€666.00
07.02.24
07.02.24
€802.46
07.02.25
07.02.25
28.09%
08.02.25
08.02.25